Glow Lifetech Corp
CNSX:GLOW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Glow Lifetech Corp
Cost of Revenue
Glow Lifetech Corp
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Glow Lifetech Corp
CNSX:GLOW
|
Cost of Revenue
-CA$245.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
Bright Minds Biosciences Inc
CNSX:DRUG
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Cost of Revenue
-$32.7m
|
CAGR 3-Years
-79%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Eupraxia Pharmaceuticals Inc
TSX:EPRX
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Glow Lifetech Corp
Glance View
Glow LifeTech Corp. is a biotechnology company, which focuses on producing nutraceutical and cannabinoid-based products with bioavailability, absorption and effectiveness. The company is headquartered in Etobicoke, Ontario. The company went IPO on 2021-03-15. The firm focuses on producing a range of high-performance, science-backed natural ingredients to power the growing demand for next generation natural health products. The firm owns a plant-based, pharma-grade drug delivery system MyCell technology, which transforms poorly absorbed natural compounds into enhanced, water-compatible concentrates that unlock the full healing potential of the valuable compounds. The Company’s range of MyCell Technology enhanced ingredients are available in water-compatible liquid concentrates. The firm is also focused on the development of various MyCell cannabidiol (CBD) and tetrahydrocannabinol (THC) water-soluble solutions.
See Also
What is Glow Lifetech Corp's Cost of Revenue?
Cost of Revenue
-245.2k
CAD
Based on the financial report for Dec 31, 2024, Glow Lifetech Corp's Cost of Revenue amounts to -245.2k CAD.
What is Glow Lifetech Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
-1 247%
Over the last year, the Cost of Revenue growth was -1 247%.
